arrow
W

Wei Yao

chinese academy of sciences
H指数:21
被引数:1,543

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Osimertinib with chemotherapy as fi rst-line therapy for patients with locally advanced or metastatic epidermal growth factor receptor mutation (EGFRm) non-small cell lung cancer (NSCLC): A prospective, multi-centre, real-world study (FOREFRONT)

奥希替尼联合化疗作为一线疗法用于局部晚期或转移性表皮生长因子受体突变(EGFRm)非小细胞肺癌(NSCLC)患者的治疗:一项前瞻性、多中心、真实世界研究(FOREFRONT)

2024-12-010
PRE